Mesangial cell proliferation is an important feature of GBM glomerulonephritis. mesangial proliferative glomerulonephritis (GN), which Background. Glucocorticoids are widely used for the treatprogresses to end-stage renal disease [1, 2] . Mesangial ment of glomerulonephritis, but the mechanism of cell cycle cell proliferation accompanies a wide variety of renal inhibition by glucocorticoids is poorly understood at a molecular level.
eration of mesangial cells induced by growth-promoting factors [14] .
Glucocorticoids are widely used for the treatment of treated anti-GBM GN group, prednisolone p.o. was started on the same day as the anti-GBM antibody injec-GN. Glucocorticoid administration has been reported to ameliorate mesangial proliferative GN in humans [15, 16] .
tion and was continued for 10 days. In the anti-GBM GN without prednisolone group, saline p.o. was started on the However, the mechanism of the antiproliferative effects of glucocorticoid is poorly understood at a molecular level same day as the anti-GBM antibody injection and was continued for 10 days. Rats were sacrificed on days 0, 5, in mesangial cells. The functional connection between the glucocorticoid-regulated transcriptional events and the and 10 (N ϭ 5 at each time point) after anti-GBM antibody injection. Immediately after sacrifice, renal biopsies were cell cycle arrest of mesangial cells is not known.
The purpose of this study was to investigate the mecha-taken from each animal for histologic studies, and glomeruli were isolated by differential sieving for protein extrac-nisms of glucocorticoid-induced cell cycle arrest in mesangial cells and in anti-glomerular basement membrane tion and mRNA detection as described previously [17] . (GBM) GN. To determine whether the inhibitory mech-Expression vectors and reporter constructs anisms of glucocorticoid on mesangial cell proliferation are mediated by CDK inhibitors, we investigated the C/EBP␣ human cDNAs were generous gifts of Dr. H. Baumann [19] . The p21 CIP1 reporter construct used for expression of CDK inhibitors (p27 Kip1 , p21 CIP1 ) and activities of CDK2 and CDK4 in rat mesangial cells and in the CAT assays contained human p21 CIP1 promoter from residues Ϫ2280 to 139 cloned upstream of the CAT gene glomeruli of anti-GBM rats treated with glucocorticoids. We demonstrated that dexamethasone inhibited mesan-(generous gift of Dr. G.L. Firestone and Dr. B. Vogelstein) [20, 21] . The pCH110 reporter construct contains the SV40 gial proliferation mainly via transcriptional up-regulation of p21 CIP1 . We also examined the effect of dexameth-promoter upstream of the ␤-galactosidase gene (Pharmacia Biotechnology Inc., Uppsala, Sweden) [22] . asone on a deletion mutant of p21 CIP1 -promoter-CAT activity and the effect of cotransfection of CCAAT/ Transient transfection and CAT assay enhancer binding protein (C/EBP␣) on p21 CIP1 -promoter-CAT activity. Finally, we demonstrated that glu-Rat mesangial cells were transfected by the electroporation method. Data are representative of at least four cocorticoid administration ameliorated cell proliferation and proteinuria in anti-GBM-induced rat proliferative independent experiments performed in duplicate and are expressed as "N-fold increase in luciferase activity" GN at least partially by the induction of p21 CIP1 . calculated relative to the indicated level of p21 CIP1 promoter activity. Plasmid DNAs (10 g) were transfected METHODS by the electroporation method. For experiments per-Mesangial cell culture formed in exponentially growing cells, CAT activity was measured 48 hours after transfection using an enzyme-Mesangial cell strains from male Wistar-Kyoto rats were isolated and characterized as previously reported linked immunosorbent assay (ELISA) kit (Boehringer). Normalization was achieved by cotransfecting 3.0 g of [17]. Cells were maintained in RPMI 1640 medium supplemented with 20% fetal bovine serum, 100 U/mL peni-pCH110, a ␤-galactosidase reporter construct, as an internal control for the transfection efficiency. For mito-cillin, 100 g/mL streptomycin, 5 g/mL of insulin, 5 g/mL of transferrin, and 5 ng/mL selenite at 37ЊC in a 5% CO 2 gen-stimulated p21 CIP1 reporter expression, cells were stimulated with 20 ng/mL PDGF with or without dexa-incubator. Cells used in experiments were from four to nine passages. After an initial incubation in medium plus methasone for 24 hours from one day following the transfection. ␤-Galactosidase activities were measured ac-20% fetal calf serum (FCS) until approximately 80% confluence, the cells were incubated in medium containing cording to the Promega (Madison, WI, USA) protocol. dexamethazone (10 Ϫ6 mol/L) plus 20 ng/mL platelet-Antisense oligonucleotide derived growth factor (PDGF)-BB (Boehinger, Mannheim, Germany) for the indicated times.
Antisense and scrambled random sequence oligonucleotides (oligonucleoside phospharothioates) against p21 CIP1 Animal model were synthesized by a DNA synthesizer (Model 8909; Perseptive Biosystems, Cambridge, MA, USA) and Female Wistar-Kyoto rats weighing 200 to 250 g were used in the present study. Experimental proliferative GN purified by an high-performance liquid chromatography (HPLC). The p21 CIP1 antisence oligonucleotide was de-was induced by an intravenous administration of anti-GBM serum at a dose of 0.25 mL/kg body weight as signed around the start codon of rat p21 CIP1 , with the sequence 5Ј-GACATCACCAGGATCGGACAT-3Ј and described previously [18] . We divided the rats into three groups: the control group, the anti-GBM GN without the scrambled random sequence control oligonucleotide p21 CIP1 5Ј-TGGATCCGACATGTCAGA-3Ј, have been prednisolone group, and the anti-GBM GN with prednisolone group. In the control group, we administered sa-used previously to synthesize oligonucleotides to interfere with p21 CIP1 expression in rat vascular smooth muscle line instead of anti-GBM antibody. In the glucocorticoid-cells [23] . For the liposome-mediated transfection proce-SSPE and 0.5% SDS, and then exposed to Fuji x-ray dure, 10 Ϫ6 mol/L oligonucleotide was mixed with cationic film (Fuji Photo Film, Kanagawa, Japan) for three to liposome using a DOSPER liposomal transfection reagent seven days at Ϫ80ЊC. transfection kit (Boehringer Mannheim) in serum-free [ 3 H] thymidine incorporation medium and incubated for 24 hours for 37ЊC [24] . We used fluorescein-isothiocyanate-labeled oligonucleotides Mesangial cells were plated in 24-well plates, incu-(5Ј-GACATCACCAGGATCGGACAT-3Ј) to show the bated in medium containing 20% FCS for 24 hours, and efficiency of the oligonucleotide transfection. Proliferatthen incubated in medium plus 20% FCS until approxiing mesangial cells were rinsed once in serum-free memately 70% confluence. Next, they were incubated in dium, incubated preliminarily with an oligonucleotideseveral mediums containing different concentrations of liposome solution, and then incubated in medium condexamethasone (10 Ϫ5 to 10 Ϫ10 mol/L) plus 20 ng/mL taining 0.5% serum for 24 hours in humidified incubators PDGF for 24 hours for indicated times. For the last four at 37ЊC with 5% CO 2 . The percentage of cells that were hours, the cells were pulsed with 1 Ci [ 3 H] thymidine positive for uptake of fluorescein isothiocyanate-labeled (Amersham) and counted in Aquasol-2 scintillation oligonucleotides was determined by ultraviolet fluorescocktail (NEN Research Products, Boston, MA, USA). cence microscopy. After incubation with antisense or scrambled random sequence control oligonucleotides Cell cycle analysis by flow cytometry (10 Ϫ6 mol/L) for 24 hours, mesangial cells were incubated Mesangial cells were cultured in a 75 cm 2 flask. Next, with 10 Ϫ6 mol/L dexamethasone.
after an initial incubation in RPMI 1640 medium plus 20% FCS until approximately 80% confluence, the cells Western blot analysis were incubated in medium with or without dexametha-The proteins were extracted from mesangial cells or isosone (10 Ϫ6 mol/L) plus 20 ng/mL PDGF for 24 hours. The lated glomeruli using an extraction buffer containing cells were stained with propidium iodide and analyzed by 50 mmol/L ␤-glycerophosphate, pH 7.3, 1.5 mmol/L flow cytometry using a Coulter flow cytometer (Coulter EGTA, 0.1 mmol/L Na 3 VO 4 , 1 mmol/L dithiothreitol Corporation, Hialeah, FL, USA), and the percentages (DTT), 10 g/mL leupeptine, 10 g/mL aprotinine, of the cells in the G1, S, and G2/M phases were deter-2 g/mL pepstatin A, and 1 mmol/L benzamidine as mined [26] . described previously [25] . Fifty micrograms of protein were resolved in sodium dodecyl sulfate-polyacrylamide Immunoprecipitation and CDK4, CDK2 kinase assay gel electrophoresis (SDS-PAGE), and the proteins were Immune complex kinase assay was performed using then transferred to an Immobilon P membrane (Daiichiessentially the same methods described by Matsushime kagaku, Tokyo, Japan). To detect p27 Kip1 , p21 CIP1 , cyclin et al [27] . Cell lysates of mesangial cells and isolated D1, cyclin E, CDK2, and CDK4, the membrane was inglomeruli were incubated for two hours at 4ЊC with 20 L cubated with antibodies (Santa Cruz Biotechnology, of protein G-plus agarose (Oncogene Science, Union-Santa Cruz, CA, USA) at a dilution of 1:1000 in TBS dale, NY, USA) and 10 L of anti-rat-CDK4 antibody or containing 0.5% Tween 20 for two hours at 37ЊC and anti-rat-CDK2 antibody (Santa Cruz Biochemical Inc.), then visualized using the ECL chemiluminescence system and immune complexes were recovered by centrifuga-(Amersham, Little Chalfort, UK). Films were scanned tion. Immunoprecipitated proteins were suspended in using an Epson scanner (Nagano, Japan). Signals on West-30 L of kinase buffer (50 mmol/L HEPES, pH 7.5, ern blots were quantitated by densitometry using an image 10 mmol/L MgCl 2 , 1 mmol/L dithiothreitol) containing analysis software application (NIH Image 1.47). substrate (0.2 g of soluble glutathione S-transferase-pRb fusion protein for the CDK4 kinase assay, and his-Northern blot analysis tone H1; Boehringer Mannheim for the CDK2 assay) The mRNA was extracted from isolated glomeruli using and 2.5 mmol/L EGTA, 10 mmol/L ␤-glycerophosphate, TRI-REAGENT (Life Technologies, Gaithersburg, 1 mmol/L NaF, 20 mol/L ATP, and 10 Ci of [␥-32 P] MD, USA). Twenty micrograms of total RNA samples ATP (6000 Ci/mmol; NEN, DuPont, Boston, MA, USA). were separated on 1% agarose-formaldehyde-MOPS After incubation for 30 minutes at 30ЊC with occasional gels and transferred to Hybond-N hybridization memmixing, the samples were boiled in polyacrylamide gel branes (Amersham). A series of 2.7 kb full-length murine sample buffer containing SDS and separated by electro-p21 CIP1 cDNAs [11] was labeled by the random priming phoresis. Phosphorylated proteins were visualized by aumethod and used as probes for Northern hybridization. toradiography. Following hybridization, the membranes were washed Immunoprecipitated protein was resolved in SDStwice for five minutes at room temperature in 5 ϫ SSPE PAGE and analyzed by Western blotting with p21 CIP1 , and 0.5% SDS, twice at 37ЊC for 15 minutes in 1 ϫ SSPE and 0.5% SDS, once at 37ЊC for 15 minutes in 0.1 ϫ CDK2, and CDK4 antibody.
Fig. 1. Effect of dexamethasone on [ 3 H]-thymidine incorporation and cell cycle progression in rat mesangial cells. (A)
Rat mesangial cells were treated with (10 Ϫ6 to 10 Ϫ9 mol/L) or without dexamethasone for 24 hours, with pulse radio labeling for the last four hours with [ 3 H]thymidine. Radioactivity of cell lysate was quantitated by scintillation counting. (B) Rat mesangial cells were treated with (10 Ϫ6 mol/L) or without dexamethasone for 24 hours and then stained with propidium iodide solution.
The DNA content of cell nuclei was performed by flow cytometry.
Histologic examination Effect of dexamethasone on CDK2 and CDK4
activities and protein levels of p21 CIP1 , p27 KIP1 , cyclin Renal tissues obtained from control, saline-treated, or D1, cyclin E, CDK2, and CDK4 in rat mesangial cells prednisolone-treated anti-GBN GN rats were fixed in formalin overnight and then dehydrated and paraffin
To determine the inhibitory mechanisms of dexamethembedded. Thin sections were examined with periodic asone on cell cycle progression, we examined the effects acid-Schiff staining as described previously [28] .
of dexamethasone on protein expression of the following G1/S-regulated genes: p21 CIP1 , p27 KIP1 , cyclin D1, cyclin Statistical analysis E, CDK2, and CDK4. Rat mesangial cells were treated The results were given as means Ϯ SEM. The differwith or without (10 Ϫ6 mol/L) dexamethasone for 24 hours ences were tested using analysis of variance. P Ͻ 0.05 in the presence of 20 g/mL PDGF. Rat mesangial cells was considered significant. treated without dexamethasone or PDGF served as the control. Twenty micrograms of cell lysate protein were used for Western blot analysis. The protein expression RESULTS of p21 CIP1 , p27 KIP1 , cyclin D1, cyclin E, CDK2, and CDK4
Dexamethasone inhibited [ 3 H]-thymidine
was determined by Western blot analysis using specific incorporation and cell cycle progression antibodies. Figure 2A demonstrates that dexamethasone induced by PDGF in rat mesangial cells significantly increased the expression of p21 CIP1 but not the expressions of p27 KIP1 , cyclin D1, cyclin E, CDK2, To determine the effects of dexamethasone on cell cycle progression, dexamethasone was added to asynchronous and CDK4.
To determine the effects of dexamethasone on the mesangial cells. Various concentrations of dexamethasone were added to mediums containing 20 ng/mL PDGF CDK activities, CDK2 and CDK4 activities were measured in PDGF-stimulated mesangial cells with or with-for 24 hours, and [ 3 H]-thymidine incorporation was measured. As shown in Figure 1A , PDGF-stimulated [ 3 H]-out dexamethasone (10 Ϫ6 mol/L). Equal amounts of cell extract (1 mg) were immunoprecipitated with antibodies thymidine incorporation is inhibited dose dependently in the presence of dexamethasone. Cell cycle analysis by against CDK2 or CDK4. The kinase activities of the immunoprecipitates were assayed using histone H1 for flow cytometry revealed that dexamethasone (10 Ϫ6 mol/L) reduced the percentage of PDGF-stimulated increments CDK2 and GST-Rb for CDK4. Figure 2B shows that the kinase activities associated with CDK2 and CDK4 of S phase and G2/M phase (Fig. 1B) .
Fig. 2. Effect of dexamethasone on CDK2
and CDK4 kinase activities and protein levels of p21 CIP1 , p27 KIP1 , cyclin D1, cyclin E, CDK2, and CDK4 in rat mesangial cells. (A) Western blot analysis. Rat mesangial cells were treated with or without (10 Ϫ6 mol/L) dexamethazone (Dex) in the presence or absence of 20 ng/mL PDGF for 24 hours. Twenty micrograms of cell lysate protein were used for Western blot analysis. The protein production of p21 CIP1 , p27 KIP1 , cyclin D1, cyclin E, CDK2, and CDK4 was determined by Western blot analysis using specific antibodies. (B) Kinase assay. CDK2 and CDK4 activities were measured in PDGFstimulated mesangial cells with or without Dex (10 Ϫ6 mol/L). Equal amounts of cell extract (1 mg) were immunoprecipitated with antibodies against CDK2 or CDK4. The kinase activities of the immunoprecipitates were assayed using histone H1 for CDK2 and GST-Rb for CDK4. Western blot of p21 CIP1 was performed after immunoprecipitation with CDK2 or CDK4.
Fig. 3. Deletion analysis of the p21 CIP1 promoter defines a 297 bp glucocorticoid-responsive element (GRE).
Rat mesangial cells were transiently transfected with a series of p21 CIP1 -CAT reporter plasmids that contains indicated 5Ј deletions of the p21 CIP1 promoter and ␤-galactosidase plasmid. Cells were treated with (10 Ϫ6 mol/L) or without dexamethasone for 24 hours, and then the CAT-specific activity was determined using ELISA CAT assay kits. The CAT activity was normalized by ␤-galactosidase activity. The reported values are an average of four independent experiments (mean Ϯ SEM). *P Ͻ 0.05 vs. CAT activity of Ϫ2280 plasmid.
were up-regulated in the presence of PDGF and re-Deletion analysis of the p21 CIP1 promoter defines a 297 bp glucocorticoid-responsive region pressed in dexamethazone-treated cells. To confirm whether or not the decrease of CDK2 and CDK4 activity
To determine which region within the p21 CIP1 -prowas mediated by increment of p21 CIP1 level, we performed moter was responsible for the glucocorticoid-mediated Western blot analysis of p21 CIP1 after immunoprecipitatranscriptional activation, rat mesangial cells were trantion with CDK2 or CDK4. The level of p21 CIP1 associated siently transfected with a series of p21 CIP1 -CAT reporter with CDK2 was increased in the dexamethasone-treated plasmids that contain indicated 5Ј deletions of the p21 CIP1 mesangial cells (Fig. 2B ). This suggested that the increpromoter plasmid (Fig. 3) . Mesangial cells were treated ment of p21 CIP1 mediated the decrease of CDK2 kinase with or without (10 Ϫ6 mol/L) dexamethasone for 24 activity. The level of p21 CIP1 associated with CDK4 was hours, and CAT-specific activity was determined using also increased in the dexamethasone-treated mesangial ELISA CAT assay kits. The CAT activity was normalcell ( Fig. 2B ). This suggested that the increment of p21 CIP1 ized by ␤-galactosidase activity. Dexamethasone stimulated the transcriptional activity of p21 CIP1 -CAT constructs mediated the decrease of CDK4 kinase activity.
Fig. 5. Mutation of the C/EBP␣ DNA binding site reduced dexamethasone inducibility of p21 CIP1 promoter activity. Cotransfection of C/EBP␣
construct significantly increased dexamethasone-induced p21 CIP1 promoter activity. Rat mesangial cells were transiently cotransfected with a wild-type p21 CIP1 promoter (ᮀ) or mutated C/EBP␣-CAT reporter ( ) plasmid, a C/EBP␣ expression plasmid, and a ␤-galactosidase plasmid. Cells were treated with or without (10 Ϫ6 mol/L) dexamethasone for 24 hours, and CAT-specific activity was determined using ELISA-CAT assay kits. The CAT activity was normalized by ␤-galactosidase Fig. 4 
. Time course of dexamethasone effects on protein levels of
activity. The reported values are an average of four independent experi-p21 CIP1 and C/EBP␣ in rat mesangial cells. Rat mesangial cells were ments (mean Ϯ SEM). *P Ͻ 0.05 vs. CAT activity of wild-type p21 CIP1 treated with or without (10 Ϫ6 mol/L) dexamethasone for indicated times.
promoter plasmid without dexamethasone or cotransfection of a C/EBP␣ Twenty micrograms of cell lysate protein were used for Western analyexpression plasmid. sis. The protein productions of p21 CIP1 and C/EBP␣ were determined by Western blot analysis using specific antibodies. Band intensities of p21 CIP1 were obtained by densitometry of immunoblots, and expression is presented as the fraction of expression in control (0 hour). Results are means Ϯ SEM of four independent experiments. gial cells. Cells were treated with or without (10 Ϫ6 mol/L) dexamethasone for indicated times. As shown in Figure 4 , the protein level of C/EBP␣ was augmented as early as three hours after the addition of dexamethasone, while containing the three largest p21 CIP1 promoter regions with p21 CIP1 was augmented more slowly, and did not reach deletions ending at Ϫ2280, Ϫ1846, and Ϫ1435 bp. Dexasignificant levels until 12 to 24 hours after the addition methasone inducibility of the p21 promoter was lost in of dexamethasone. These results suggested that C/EBP␣ deletions beyond Ϫ1139 bp. These results indicated that protein might be important for dexamethasone to induce the promoter sequence between nucleotides Ϫ1435 and p21 CIP1 promoter activity. Ϫ1139 of the p21 CIP1 promoter was the glucocorticoid-Next, we performed a mutation analysis of the C/EBP␣ responsive region (GRE) in rat mesangial cells.
DNA binding site in the stimulation of dexamethasoneinduced p21 CIP1 transcription. Sequence analysis of the Requirement of C/EBP␣ expression for the transcriptional stimulation of p21 CIP1 promoter promoter region of p21 CIP1 revealed no canonical glucoactivity by dexamethasone in rat mesangial cells corticoid-responsive elements, but the promoter did contain a putative C/EBP DNA binding site between nucleo-The previous studies by Cram et al demonstrated first tides Ϫ1270 and Ϫ1256, as described previously [20] . To that the expression of C/EBP␣ transcription factor was test whether the C/EBP DNA-binding site in the p21 CIP1 required for the induction of p21 CIP1 protein in hepatoma promoter contributed to the glucocorticoid-regulated cells, and second that a canonical C/EBP␣ DNA binding transcriptional activity in rat mesangial cells, the ATCC site was present at Ϫ1270 bp in the p21 CIP1 promoter [20] .
TCTGCAATTT wild-type C/EBP DNA binding site in In our current study, therefore, we examined the require-p21 CIP1 promoter was mutated to ATCCTCCCATGGTT ment of C/EBP␣ expression for induction of p21 CIP1 . At in order to eliminate the key nucleotides required for first, we examined the time course of dexamethasone effects on protein levels of p21 CIP1 and C/EBP␣ in rat mesan-transcription factor bindings in the manner described Wistar-Kyoto rats were divided into three groups: the control group, the anti-GBM GN without prednisolone group, and the anti-GBM GN with prednisolone group. In the anti-GBM GN with or without prednisolone group, we administered prednisolone (1 mg/kg/day) or saline for 5 or 10 days just after anti-GBM antibody injection to rats. In control rats, saline was administered instead of anti-GBM antibody. (A) Histologic examinations of periodic acid-Schiff staining (ϫ400) at 10 days are shown: control group, anti-GBM GN without prednisolone group, and anti-GBM GN with prednisolone group. (B) Levels of proteinuria of the control group, anti-GBM GN without prednisolone group, and anti-GBM GN with prednisolone group. Administration of prednisolone significantly ameliorated proteinuria of anti-GBM GN at 5 and 10 days. Results are means Ϯ SEM of five independent experiments (*P Ͻ 0.05). (C ) Western blot analysis and Northern blot analysis from glomeruli of control group, anti-GBM GN without prednisolone group, and anti-GBM GN with prednisolone group. The level of p21 CIP1 protein and mRNA expression increased in glomeruli of anti-GBM GN with prednisolone group compared with that of anti-GBM GN without prednisolone group, suggesting a transcriptional increment of p21 CIP1 expression in vivo. (D) The protein levels of CDK2 and CDK4 were the same in the glomeruli of the anti-GBM GN with prednisolone group compared with that of the anti-GBM GN without prednisolone group. (E) CDK2 and CDK4 activities were measured in isolated glomeruli of control group, anti-GBM GN without prednisolone group, and anti-GBM GN with prednisolone group. Equal amounts of cell extract (1 mg) were immunoprecipitated with antibodies against CDK2 and CDK4. The kinase activities of the immunoprecipitates were assayed using histone H1 for CDK2 and GST-Rb for CDK4. Western blot analysis of p21 CIP1 after immunoprecipitation with CDK2 or CDK4 revealed that protein levels of p21 CIP1 associated with CDK2 and CDK4 were increased in the glomeruli of anti-GBM GN with prednisolone group.
previously for hepatoma cells [20] . These p21 CIP1 pro-site in rat mesangial cells, whereas the reporter plasmid containing the wild-type C/EBP DNA-binding site was moter fragments containing either the wild-type or the C/EBP DNA-binding site mutation were linked up-responsive to dexamethasone. Transient expression of C/EBP␣ increased the CAT activity significantly in the stream of the thymidine kinase (tk) minimal promoter sequence driving the bacterial CAT gene [20] . As shown wild-type p21 CIP1 promoter fragment but not in the cells transfected with the reporter plasmid mutated in the in Figure 5 , dexamethasone failed to induce CAT activity in the reporter-plasmid-mutated C/EBP DNA binding C/EDP␣ binding site. Glucocorticoid administration ameliorated prednisolone group accumulated increased amounts of p21 CIP1 protein and mRNA compared with glomeruli of cell proliferation and proteinuria in anti-GBM the anti-GBM GN without prednisolone group (Fig. 6C ).
antibody-induced rat proliferative GN at least
In contrast, Western blot analysis of CDK2 and CDK4 partially via the induction of p21 CIP1 with total cell lysate of isolated glomeruli showed no To determine the inhibitory effect of glucocorticoid changes in the protein levels of CDK2 and CDK4 in the in mesangial cell proliferation in vivo, we established glomeruli of the anti-GBM GN with prednisolone group three groups of rats: a control group, an anti-GBM GN (Fig. 6D ). without prednisolone (saline-treated) group, and an anti-To determine the effects of prednisolone on the CDK GBM GN with prednisolone group. In the anti-GBM activities in glomeruli of the anti-GBM antibody-induced GN with prednisolone group, prednisolone (1 mg/kg/ GN group, an immunocomplex kinase assay was perday) was administered just after the anti-GBM antibody formed from glomeruli of the control group, anti-GBM injection to rats for 5 or 10 consecutive days. As shown GN without prednisolone group, and anti-GBM GN with in Figure 6A , glomeruli of the anti-GBM GN without prednisolone group. Kinase activities of CDK2 and prednisolone group showed a marked increase in mesan-CDK4 of glomeruli from the anti-GBM GN with prednigial proliferation and crescent formation on day 10 comsolone group were significantly decreased compared with pared with the control group. In contrast, the glomeruli that of anti-GBM GN without prednisolone group, as of the anti-GBM GN with prednisolone group showed shown in Figure 6E . Western blot analysis of p21 CIP1 after a significant amelioration in mesangial proliferation and immunoprecipitation with CDK2 or CDK4 revealed that crescent formation compared with the glomeruli of the protein levels of p21 CIP1 associated with CDK2 and CDK4 anti-GBM GN without prednisolone group on day 10 were increased in the glomeruli of anti-GBM GN with (Fig. 6A) . The level of proteinuria in the anti-GBM GN prednisolone group. with prednisolone group was ameliorated compared with Effect of p21 CIP1 antisense and scrambled random the level of the anti-GBM GN without prednisolone sequence phosphorothioate oligonucleotide on p21 CIP1 group at both 5 and 10 days (Fig. 6B) .
protein expression and dexamethasone-induced-Furthermore, we performed Western blot analysis, inhibition of [ 3 H]-thymidine incorporation in rat Northern blot analysis, and CDK2 and CDK4 assays mesangial cells from isolated glomeruli in the control group, anti-GBM GN without prednisolone group, and anti-GBM GN with
To test whether interference with p21 CIP1 expression using an antisense oligonucleotide approach influenced prednisolone group. Glomeruli of anti-GBM GN with dexamethasone-induced cell cycle arrest, protein synthe-gial cells. Fourth, our previous report demonstrated that overexpression of p21 CIP1 caused cell cycle arrest in rat sis and [ 3 H]-thymidine incorporation were measured in rat mesangial cells transiently transfected with 10 Ϫ6 mol/L mesangial cells [14] . To our knowledge, this is the first report showing that of p21 CIP1 antisense and scrambled random sequence phosphorothioate oligonucleotides. At first, we used prednisolone administration increases p21 CIP1 protein levels in the glomerulus in vivo. Furthermore, this report fluorescein-isothiocyanate-labeled oligonucleotides to show the efficiency of the oligonucleotide transfection.
is the first to propose a mechanism of glucocorticoid inhibition of mesangial cell proliferation and proteinuria We observed that oligonucleotides were taken up and concentrated in the nuclei of 85 to 90% of cells.
in proliferative GN rats. Our data from immunoblot, Northern blot, and immunohistological analyses clearly As shown in Figure 7 (lower panel), transfection with p21 CIP1 antisense phosphorothioate oligonucleotide sig-demonstrate that glucocorticoid increases p21 CIP1 mRNA and protein levels in glomeruli of rat anti-GBM GN. nificantly inhibited dexamethasone-induced p21 CIP1 protein expression in rat mesangial cells. p21 CIP1 protein
The evidence from the present in vitro and in vivo experiments strongly suggests that glucocorticoid at least partly expression was inhibited by p21 CIP1 antisense phosphorothioate oligonucleotide but not by p21 CIP1 scrambled ran-inhibited mesangial proliferation via a transcriptional induction of p21 CIP1 in anti-GBM GN. However, in our dom sequence phosphorothioate oligonucleotide. p21 CIP1 antisense oligonucleotide abolished the inhibitory effects experiments, p21 CIP1 actually was demonstrated only in isolated glomeruli and not in mesangial cells in vivo of dexamethasone on PDGF-stimulated [ 3 H]-thymidine incorporation in rat mesangial cells (Fig. 7, upper panel) .
( Fig. 6 ). It is possible that prednisolone might induce p21 CIP1 in other glomerular cells, particularly in the epithelial cells.
DISCUSSION
Many glomerular diseases are characterized by mesan-In the present study, we demonstrate that dexamethagial cell proliferation and accumulation of mesangial exsone significantly increased the protein expression and tracellular matrix [1, 2] . The mechanisms of regulation promoter activity of p21 CIP1 in rat mesangial cells. Deleof the mesangial cell cycle are largely unknown. Shanktion analysis revealed that dexamethasone inducibility land et al recently showed that the normal glomerulus of the p21 CIP1 promoter was present between Ϫ1435 and has a high endogenous expression of p27 Kip1 that de-Ϫ1139 bp. Dexamethasone inducibility of p21 CIP1 procreases with the initiation of the mesangial cells' prolifermoter activity required the presence of the C/EBP␣ ative response and then normalizes with the resolution DNA binding site in the p21 CIP1 promoter region and of the mesangial cell proliferation in the Thy-1.1 model C/EBP␣ protein. We also demonstrated that glucocortiof experimental mesangial proliferative GN [13]. Furcoid administration at least partially ameliorated cell thermore, they found that p21 CIP1 has low levels of expresproliferation and proteinuria in anti-GBM antibodysion in the normal rat glomerulus [13] . Recently, in our induced rat proliferative GN via the induction of p21 CIP1 . own investigation of the mechanisms of the cell cycle Glucocorticoid has been widely used as a therapy for regulation of rat mesangial cells, we demonstrated that mesangial proliferative GN [15, 16] . Glucocorticoid is FCS and PDGF stimulated CDK2 and CDK4 kinase known to inhibit or stimulate the in vivo and in vitro activity and that these stimulatory activities were inhibgrowth of many types of normal and transformed cells ited by overexpressions of CDK inhibitor (p16 INK4 and [29-31]. However, the molecular mechanisms of the anti-p21 CIP1 ) [14] . These studies indicated that mesangial cell mitogenic effects of glucocorticoid in mesangial proliferproliferation is regulated by a precise balance of CDK ative disease have not been clarified. This report is the kinase and CDK inhibitors. The present study demonfirst, to our knowledge, to demonstrate the involvement strates that among these CDK inhibitors, p21 CIP1 plays a of p21 CIP1 in the inhibitory effects of dexamethasone on key role in the mesangial cell cycle not only in vitro but mesangial cell proliferation both in vitro and in vivo. also in vivo. Furthermore, other recent studies demon-We believe that p21 CIP1 may play a critical role in the strated that p21 CIP1 induces cell cycle-independent effects glucocorticoid-induced cell cycle arrest in mesangial cells such as cell differentiation and apoptosis in myocytes for the following reasons. First, the protein level of and vascular smooth muscle cells [23, 32, 33] . The effects p21 CIP1 was increased, and cell cycle progression was inmay influence mesangial cell transformation and antihibited in the presence of glucocorticoid. Second, these inflammatory mechanisms in the rat GN model. inhibitory effects were accompanied by a reduction of This study demonstrates that dexamethasone stimu-CDK2 and CDK4 kinase activities, whereas the protein lates the promoter activity of p21 CIP1 and increases the levels of CDK2, CDK4, p27 Kip1 , cyclin D, and cyclin E p21 CIP1 protein expression in mesangial cells. We define were not changed in the presence of dexamethasone.
the GRE as bases Ϫ1435 to Ϫ1139 of the p21 CIP1 pro-Third, antisense oligonucleotide for p21 CIP1 reversed the moter sequence. This result is in agreement with the Firestone group's reports on hepatoma cell lines [20, 34] . antiproliferative glucocorticoid action in cultured mesan-tion of C/EBP␣ in dexamethasone-induced p21 CIP1 upregulation should be analyzed in future studies.
In conclusion, the present study provides new insights into the pathophysiological role of glucocorticoid in proliferative GN. These data indicate a functional link between the glucocorticoid receptor signaling pathway and the transcriptional control of p21 CIP1 that mediates cell cycle arrest, as well as an enhancement of this linkage by C/EBP␣, in mesangial cells in vitro and in rat proliferative GN.
factor ␤ because, as far as we could find, there are no 18. Kawasaki K, Yaoita E, Yamamoto T, et al: Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associ-C/EBP␣ elements in those promoters. The precise func-
